-
Pfizer Criticizes Sudden Change in Coronavirus Vaccine Dosing Regime in the U.K.
Post on 1/4/21
-
Pfizer's Next Multibillion-Dollar COVID Vaccine Move
Post on 1/4/21
-
Why Did Johnson & Johnson Cut the Size of Its Coronavirus Vaccine Trial?
Post on 1/4/21
-
Should Investors Be Worried About Pfizer and BioNTech's Coronavirus Vaccine Rollout?
Post on 1/4/21
-
Why Teladoc Stock Soared 139% in 2020
Post on 1/4/21
-
Acorda Therapeutics Completes One-for-Six Reverse Stock Split
Post on 1/3/21
-
New Dermatology Company Resilia Pharmaceuticals Begins Operations
Post on 1/3/21
-
BrainStorm Issues 2020 Letter to Shareholders
Post on 1/3/21
-
Andrew Hanna Explains the Important Role of Community Pharmacies in Distributing COVID-19 Vaccines
Post on 12/29/20
-
Is Johnson & Johnson Stock a Buy?
Post on 12/24/20
-
Pfizer and BioNTech to Supply Feds With 100 Million Additional Doses of Coronavirus Vaccine
Post on 12/24/20
-
GBS Prices IPO
Post on 12/23/20
-
Outlook Therapeutics Reports Financial Results for Fiscal Year 2020 and Provides Corporate Update
Post on 12/23/20
-
Sale of Kantar Health Kicks Off Bain Makeover
Post on 12/23/20
-
Is Pfizer's COVID Vaccine Growth Story Already Over?
Post on 12/23/20
-
What Pfizer Wants You to Know About Its COVID Vaccine
Post on 12/23/20
-
GBS Prices of IPO
Post on 12/23/20
-
Acorn Bioventures Invests in Cyclacel Pharmaceuticals
Post on 12/22/20
-
SCYNEXIS Closes of $85 Million Public Offering of Common Stock
Post on 12/22/20
-
Tonix Pharmaceuticals Acquires Exclusive License to University of Geneva Technology
Post on 12/22/20
-
Pfizer and BioNTech's Coronavirus Vaccine Approved in Europe
Post on 12/22/20
-
Etsy: A COVID E-Commerce Winner That Will Keep Winning In 2021
Post on 12/22/20
-
Provention Bio Announces Addition to NASDAQ Biotechnology Index
Post on 12/21/20
-
Gabelli Healthcare & WellnessRx Trust Issues of $40 Million of 4.00% Series C Cumulative Preferred Shares
Post on 12/21/20
-
Does Pfizer's Vaccine Authorization Improve Moderna's Chances?
Post on 12/21/20
New York
